News & Updates

An android fat deposition pattern, independent of body mass index (BMI), appears to predict higher odds of nonalcoholic fatty liver disease (NAFLD) in both men and women, but its effect on fibrosis is only seen in females, suggests a US study.

Alcohols and alcohol-based disinfectants are not strong enough to eliminate the hepatitis E virus (HEV), except for one commercial ethanol-based product that has phosphoric acid, a study has shown. This finding may help develop measures to reduce transmission in clinical practice.

People with lower muscle mass and grip strength are at increased risk of developing severe nonalcoholic fatty liver disease (NAFLD), reveals a study.

Counselling for alcohol dependence and abuse can help reduce the 30-day readmission rates for alcoholic hepatitis (AH), according to a study presented at the recently concluded 2022 Digestive Disease Week (DDW 2022).

A team of Singapore-based researchers has identified two blood biomarkers that not only predict clinical response to immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) patients but also the incidence of side effects from the same treatment.

Use of aspirin in the long term appears to markedly reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV), a study has shown.